Alessandro Cozzi‐Lepri

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

Giovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi‐Lepri et al. · The Lancet Rheumatology · 2020 · 997 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +6

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

Antonella d’Arminio Monforte, Alessandro Cozzi‐Lepri, Giovanni Rezza et al. · AIDS · 2000 · 560 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Linda Wittkop, Huldrych F. Günthard, Frank de Wolf et al. · The Lancet Infectious Diseases · 2011 · 387 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

Birgit Grund, Jason V. Baker, Steven G. Deeks et al. · PLoS ONE · 2016 · 191 citations · Full text

Public Health, Immunology, Infectious Diseases +16

Production of β‐Chemokines in Human Immunodeficiency Virus (HIV) Infection: Evidence that High Levels of Macrophage Inflammatory Protein‐1β Are Associated with a Decreased Risk of HIV Disease Progression

Henrik Ullum, Alessandro Cozzi‐Lepri, Jette Victor et al. · The Journal of Infectious Diseases · 1998 · 127 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15